Association of metalloproteinase gene polymorphisms with systemic sclerosis in the European Caucasian Population

Journal of Rheumatology

Volumn 37, Issue 3, 2010, Pages 599-602

  Wipff, Julien ^a   Dieude, Philippe ^a   Avouac, Jerome ^a   Tiev, Kiet ^b   Hachulla, Eric ^c   Cracowski, Jean Luc ^d   Diot, Elizabeth ^e   Sibilia, Jean ^f   Mouthon, L U C ^a   Meyer, Olivier ^a   Kahan, Andre ^a   Boileau, Catherine ^a   Allanore, Yannick ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIV LILLE   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e CHU BRETONNEAU   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Metalloproteinase; Single Nucleotide Polymorphism; Systemic Sclerosis

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

AGED; CASE-CONTROL STUDIES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROFIBRILS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 77949733293     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090973     Document Type: Article

References (14)

1. Herrmann K, Heckmann M, Kulozik M, Haustein UF, Krieg T. Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J Invest Dermatol 1991;97:219-22.
2. Verrecchia F, Mauviel A. Transforming growth factor-ß and fibrosis. World J Gastroenterol 2007;13:3056-62.
3. Wipff J, Allanore Y, Boileau C. FBN-1/TGF-ß relationships and fibrillopathies. Med Sci (Paris) 2009;25:161-7.
4. Dijke P, Arthur HM. Extracellular control of TGFß signalling in vascular development and disease. Mol Cell Biol 2007;8:857-69.
5. Wallis DD, Tan FK, Kielty CM, Kimball MD, Arnett FC, Milewicz DM. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma). Arthritis Rheum 2001;44:1855-64.
6. Wallis DD, Tan FK, Kessler R, Kimball MD, Cretoiu JS, Arnett FC, et al. Fibrillin 1 abnormalities in dermal fibroblast cultures from first-degree relatives of patients with systemic sclerosis (scleroderma). Arthritis Rheum 2004;50:329-32.
7. Wipff J, Giraud M, Sibilia J, Mouthon L, Meyer O, Tiev KP, et al. Polymorphic markers of the fibrillin-1 gene and systemic sclerosis in European Caucasian patients. J Rheumatol 2008;35:643-9.
8. Ashworth JL, Murphy G, Rock MJ, Sherratt MJ, Shapiro SD, Shuttleworth CA, et al. Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem J 1999;340:171-81.
9. Manabe T, Imoto K, Uchida K, Doi C, Takanashi Y. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection. Surg Today 2004;34:220-5.
10. Cowan KN, Jones PL, Rabinovitch M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 2000;105:21-34.
11. Smallwood L, Allcock R, van Bockxmeer F, Warrington N, Palmer LJ, Iacopetta B, et al. Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm. Br J Surg 2008;95:1239-44.
12. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
13. Fleischmajer R, Jacobs L, Schwartz E, Sakai LY. Extracellular microfibrils are increased in localized and systemic scleroderma skin. Lab Invest 1991;64:791-8.
14. Saitoh W, Sakamoto T, Hegab AE, Nomura A, Ishii Y, Morishima Y, et al. MMP14 gene polymorphisms in chronic obstructive pulmonary disease. Int J Mol Med 2006;17:621-6.